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CASE REPORT
Case report and immunohistochemical study of a malignant 
peripheral nerve sheath tumor in a dog
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Abstract
Malignant peripheral nerve sheath tumor is rare and rarely reported in dogs. The term neurofibroma/sarcoma 
is classically used when the tumor is composed of Schawann and perineural cells. This work describes the clinical, 
histopathological, and immunohistochemical case of a subcutaneous malignant peripheral nerve sheath tumor, most 
likely a malignant neurofibroma located in the pelvic member of a Rottweiler dog. Histopathological features and 
immunohistochemical analysis corroborated the diagnosis, showing positivity for S-100 protein, vimentin, and CD57, 
and was useful to distinguish this type of neoplasm from other malignancies of similar morphologies.
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Resumo
O tumor maligno da bainha do nervo periférico é raro e pouco descrito em cães. Classicamente, o termo “neurofibroma/
sarcoma” é empregado quando o tumor é composto por células de Schwann e células perineurais. Neste relato são 
descritos os achados clínicos, histopatológicos e imuno-histoquímicos de um caso de tumor maligno da bainha do 
nervo periférico, provavelmente neurofibrossarcoma, localizado no subcutâneo do membro pélvico de um cão da 
raça Rottweiler. Os achados histopatológicos associados às observações imuno-histoquímicas contribuíram para o 
diagnóstico, sendo observada positividade para proteína S-100, vimentina e CD57, permitindo a diferenciação da 
neoplasia em questão de outros tumores malignos com características morfológicas similares.
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Malignant peripheral nerve sheath tumor (MPNST) 
is rare in dog, with few reports in veterinary medicine 
literature (SIRRI et al., 2016; HIGGINS et al., 2017) and 
incidence reported of 0.5% to 2.0% of all skin tumors 
(CAPLAN, 2012). Peripheral nerve sheath tumors (PNST) 
are a group of mesenchymal neoplasms, and the term 
schwannoma is used when the tumor cells are exclusively 
of Schwann-cell origin. The term neurofibroma/sarcoma, 
on the other hand, is used when the tumor consists of 
Schwann and perineural cells (HENDRICK, 2017).
The gross morphology of a MPNST includes its firm to 
soft consistency, well-circumscription and unencapsulated 
masses in the dermis or subcutis. It usually has white to 
gray coloration and sometimes slight bulges on the cut 
surface (PEKMEZCI et al., 2015; HENDRICK, 2017).
The treatment for MPNST is surgical (CAPLAN, 2012). 
The removal of the tumor and its surrounding tissues 
may be vital for the patient’s survival (PARK et al., 2011; 
TAVASOLY et al., 2013).
Diagnostic problems can be faced in canine MPNST, due 
to histopathological similarities with other mesenquimal 
tumors of fusiform cells (such as hemangiopericytoma, 
fibrosarcoma, leiomyosarcoma, and myxosarcoma). Thus, 
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the use of immunohistochemical markers is necessary for 
the correct diagnosis, prognosis, and treatment (SUZUKI 
et al., 2014; PEKMEZCI et al., 2015; SIRRI et al., 2016).
In this way, the aim of this study was to describe the 
clinical, histopathological, and immunohistochemical case 
of a MPNST, located in the pelvic member of a Rottweiler 
dog.
An 8-year-old male Rottweiler dog was submitted 
to clinical treatment at a veterinary hospital because of 
an ulcerated subcutaneous mass in its right hind limb. 
The owner reported that the time of evolution was one 
year and observed progressive growth. According to 
the dog’s history, it had been under care at a veterinary 
clinic, in which an excisional biopsy was performed, 
but a definitive diagnosis had not been established. 
At this time, the biopsy was suggestive of sarcoma. 
A previous radiographic examination of the affected 
limb had already shown that the nodule had no bone 
involvement. An increase in rod-shaped bacteria was 
also verified during this period, which was normalized 
after antibiotic therapy. Other conditions, such as 
appetite decrease, and digestive or urinary disorders 
were not noticed.
According to the clinical examination, the nodule 
measures were 12 x 8.2 x 4.5 cm, located in the right hind 
limb, on the external surface of the medial femoral region. 
The nodule was subcutaneous and had sharp, regular 
contour, with firm consistency, small surface ulceration, 
and low mobility.
Fine needle aspiration cytology (FNAC) was 
performed, but a lot of blood flowed without flaking 
tumor cells, making the diagnosis impossible through 
this method. Hemogram, serum creatinine, and 
hemoparasitological examination were within normality. 
A radiographic examination of the affected limb at mid-
lateral and dorsal positions showed that the mass was 
located in the coxofemoral joint region, extending to the 
median femoral diaphysis; it had soft tissue compatible 
with radiopacity and showed no evidence of involvement 
with adjacent bone structures.
Figure 1 –  Macroscopic and microscopic aspect of a MPNST in a Rottweiler dog. A) Intraoperative period. 
Rounded, regularly contoured and well-vascularized mass, denoting adherence to the musculature 
(shape). B) The tumoral mass was composed of neoplastic cells arranged in a storiform pattern, with 
many red blood cells. HE staining, 4x. C) Neoplastic spindle cells presented high pleomorphism, 
hyperchromatic, larger, tapered nuclei, marked nuclear atypia, and scant eosinophilic cytoplasm. 
Hypocellular myxoid areas of mucinous matrix and cellular necrosis focus is observed (*). HE staining, 
40x. D) Some neoplastic cells presented multiple nuclei and mitotic figure (shape). HE staining, 100x
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Tissue sections, processed routinely for histopathology, 
embedded in paraffin, were placed on previously silanized 
slides. Antigenic recovery by the moist heat method was 
carried out in a steamer for 20-30 min. Primary antibodies 
incubation was performed by overnight at 4°C. The 
Advance system was used for revelation. Staining was 
performed with 3.3 diaminobenzidine and counterstained 
with hematoxylin. External and/or internal controls were 
used to validate the reaction.
The antibodies immunohistochemically tested were 
vimentin (V9, Dako, 1:100), anti-S100 protein (Z0311, 
Dako, 1:800), CD57 (TB01, Dako, 1:100), desmin (D33, 
Dako, 1:100), glial fibrillary acidic protein (GFAP – Z0334, 
Dako, 1:3000), muscle-specific actin (HHF35, Dako, 
1:1000), alpha smooth muscle actin (1A4, Dako, 1:250), 
and MyoD1 (5.8A, Dako, M3512, 1:140).
Positive marking was found in about 80% of the 
cells for vimentin (marker of filaments of mesodermal 
origin), S-100 protein (marker of neural crest cells), 
and CD57 (reactivity in neural lineage cells) (Figure 2). 
Desmin, GFAP, HHF35, 1A4, and MyoD1 showed no 
immunoreactivity. Thus, the diagnosis of MPNST grade 
2, most likely a malignant neurofibroma, was concluded 
based on the histopathological and immunohistochemical 
findings, as observed by Hagen et al. (2015). The dog was 
followed clinically and presented satisfactory postoperative 
recovery. Until the present moment (15 months after the 
surgical treatment) the dog’s condition had not recurred 
and it walked normally.
MPNST include malignant schwannoma and malignant 
neurofibroma (or neurofibrosarcoma) (CAPLAN, 
2012; PEKMEZCI et al., 2015). In human medicine, 
this distinction can be made by immunohistochemical 
analysis with S100, GFAP, or other specific neural markers 
(CUNHA et al., 2012; LIU et al., 2013; ANITHAKUMARI 
et al., 2015). On the other hand, in veterinary medicine 
these entities are under the title MPNST, because several 
diagnoses are made without these ancillary test markers 
and are nonspecific or overlap in specificity in animal 
species (HENDRICK, 2017). Nevertheless, the malignant 
neurofibroma classification is referred by Tavasoly et al. 
(2013) and Hagen et al. (2015) in canine MPNST cases.
Differential diagnosis would need to include 
other spindle cell-like sarcomas, such as malignant 
schwannoma, fibrosarcoma, leiomyosarcoma, and 
perivascular wall tumors (hemangiopericytoma). The 
intertwined spindle cells microscopically observed in 
Figure 2 –  Immunohistochemical staining of a MPNST. 
Strong reactivity (about in 80% of the cells) 
for: A) Vimentin with cytoplasmic positivity 
in tumor cells (streptavidin-perosidase, SP, 
hematoxylin counterstaining ×200); B) S100 
protein, denoting tumor cells with cytoplasmic 
and matrix positivity (streptavidin-perosidase, 
SP, hematoxylin counterstaining ×200); 
and C) CD57 with cytoplasmic positivity 
(streptavidin-perosidase, SP, hematoxylin 
counterstaining ×200)
the present study were arranged in a storiform pattern, 
with elongated nuclei, high pleomorphism and many 
mitoses. These cells were similar to those observed by 
Hagen et al. (2015) in a case of MPNST, which was most 
likely a neurofibrosarcoma. Considering these results, 
distinguishing MPNST is important, and evaluating the 
expression of several markers is necessary for diagnosis 
and prognosis of neoplasms (SUZUKI et al., 2014; SIRRI 
et al., 2016; HIGGINS et al., 2017).
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The immunohistochemical analysis of the present case 
showed positivity for S-100 protein and vimentin, which 
was also observed by Tavasoly et al. (2013) and Hagen et al. 
(2015), defining the diagnosis. Thus, among the differential 
diagnoses cited by literature (SUZUKI et al., 2014; BARATT 
et al., 2015), the fibrosarcoma diagnosis was excluded in 
the present case, since fibrosarcomas are negatives for 
S-100 protein, as reviewed by Higgins et al. (2017). The 
hemangiopericytoma and leiomyosarcoma diagnoses were 
also excluded, since they present reactivity to desmin, 
HHF35, 1A4, and MyoD1 (CUNHA et al., 2012; SUSUKI 
et al., 2014; SIRRI et al., 2016), which was not seen in the 
present case. Moreover, schwannomas are positive for glial 
fibrillary acidic protein (GFAP), an intermediate astrocyte 
filament (MARLO et al., 2017), and in the present work, as in 
the evaluation of Hagen et al. (2015), the GFAP was negative.
The macroscopic aspect of the MPNST found was similar 
to that described in other scientific papers, which reported 
the subcutaneous location of this tumor (TAVASOLY et 
al., 2013). Nevertheless, uncommon location is reported by 
Baratt et al. (2015), in a case of lingual MPNST in a Chinese 
Pug Dog presenting smooth, glossy, and non-ulcerated 
surface.
The one-year evolution time reported in the present 
case is longer than in other cases in the literature for 
canine MPNST, which reported evolution times lower 
than six months (ANDREW, 1999; BARATT et al., 2015; 
GIBSON et al., 2016). No metastasis was observed in the 
present case, which is consistent with the literature, since 
less than 20% of the cases metastasize (CAPLAN, 2012). 
Nevertheless, despite the high rate of recurrence reported 
for this type of tumor (CAPLAN, 2012; HIGGINS et al., 
2017), it was not observed in the present case.
The result of the previous cytopathology, which was 
performed in the present study, often does not coincide 
with the diagnosis (ANDREW, 1999), however, it is 
important for the exclusion of diagnosis of other cutaneous 
neoplasms that have non-surgical treatment, such as 
transmissible venereal tumor (HIGGINS et al., 2017).
The diagnosis of MPNST is difficult, thus descriptions 
about the tumor, as presented here, are important. Differing 
from other reports, in this case the prognosis was favorable 
and the dog had a good recovery, without recurrences. 
Moreover, immunohistochemistry was fundamental for 
the diagnostic conclusion, and it must be considered in 
similar cases of cutaneous tumors.
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